跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
microRNA-124
首页
药物
microRNA-124
microRNA-124
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
COMPOUND FOR REGULATING ACTIVITY OF MICRORNA-124
EP 4772506 A1
申请人: JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL CO LTD
优先权: 2023
CN
EP
WO
3 件公开
Oncolytic HSV vector
US 10172893 B2
申请人: UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
优先权: 2017
US
2 件公开
Method for preparing mesenchymal stem cells of overexpressed brain-derived neurotrophic factor (BDNF) for inhibiting growth of glioma
CN 104593421 A
申请人: LIU SHUANG
优先权: 2015
CN
Organic anion transporting peptide-based cancer imaging and therapy
US 12414996 B2
申请人: DA ZEN THERANOSTICS INC
优先权: 2021
US
Application of catalpol in medicine for treating sepsis-related encephalopathy
CN 116236495 A
申请人: UNIV CHONGQING MEDICAL
优先权: 2023
CN
MicroRNA-124 nanocomposite based on tetrahedral framework nucleic acid as well as preparation method and application of microRNA-124 nanocomposite
CN 117752676 A
申请人: UNIV SICHUAN
优先权: 2023
CN
Preparation method and application of rhizoma arisaematis processed product influencing miR expression of organism
CN 119405740 A
申请人: WANG HONG
优先权: 2024
CN
药物
反馈